El Mundo on MSN7d
New advance against HIV: a single annual injection against the infection
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
BioTechniques1y
Critical role of nSMase2 in HIV replication reveals new antiretroviral target
HIV-1 is the most common type of HIV. When HIV-1 leaves infected cells ... experiments showed that PDDC selectively kills cells with actively replicating HIV-1. [2] The papers show that targeting ...